Cambrian Bioworks is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Based in the United States, Cambrian Bioworks is a startup founded in 2018. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Cambrian Bioworks is a biotechnology company focused on developing novel therapeutics to treat age-related diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.